Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting

被引:77
作者
Nobs, L
Buchegger, F
Gurny, R
Allémann, E
机构
[1] Univ Geneva, Sch Pharm, CH-41211 Geneva, Switzerland
[2] Univ Hosp Geneva, Nucl Med Serv, Geneva, Switzerland
关键词
nanoparticles; poly(DL-lactic acid); sulfhydryl functions; surface chemistry; NeutrAvidin (TM); drug targeting;
D O I
10.1016/j.ejpb.2004.04.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, NeutrAvidin(TM) was covalently bound to the surface Of poly(DL-lactic acid) (PLA) nanoparticles, with the aim of attaching targeting compounds, such as proteins, to their surface. Sulfhydryl groups were first introduced on the surface of PLA nanoparticles through a carbodiimide reaction. NeutrAvidin(TM) was then bound to the thiolated nanoparticles via a bifunctional cross-linker, which offers two binding sites, one for primary amine groups and one for thiol functions. The amount of sulfhydryl groups obtained on the surface of the nanoparticles was determined. The NeutrAvidin(TM)-labeled nanoparticles were evaluated with respect to particle size, protein concentration and biotin binding capacity. The concentration of thiol functions on the surface of nanoparticles was 105 +/- 15 mmol/mol PLA. The quantification of NeutrAvidin(TM) coupled to the nanoparticles revealed that a significant amount of the protein was covalently bound to the nanoparticles. The concentration of NeutrAvidin(TM) bound to the nanoparticles could be controlled by varying the amount of protein during the coupling reaction. The maximum concentration of NeutrAvidin(TM) attached to the particles was 6 mmol per mol of PLA. The specific activity of NeutrAvidin(TM) bound to the nanoparticles was also evaluated and results revealed that the protein maintained the capacity to bind biotin. The activity of the NAR-labeled nanoparticles was lower than expected, due to the undesired aggregation of the native NeutrAvidin(TM). Altogether, the results suggest that other proteins, such as antibodies could be coupled to the nanoparticles for active targeting. Furthermore, PLA nanoparticles bearing NeutrAvidin(TM) are interesting candidates for active targeting with biotinylated antibodies using the biotin-avidin interaction in a two step procedure. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:483 / 490
页数:8
相关论文
共 25 条
[1]  
Akasaka Y, 1988, Drug Des Deliv, V3, P85
[2]   PEG-COATED POLY(LACTIC ACID) NANOPARTICLES FOR THE DELIVERY OF HEXADECAFLUORO ZINC PHTHALOCYANINE TO EMT-6 MOUSE MAMMARY-TUMORS [J].
ALLEMANN, E ;
BRASSEUR, N ;
BENREZZAK, O ;
ROUSSEAU, J ;
KUDREVICH, SV ;
BOYLE, RW ;
LEROUX, JC ;
GURNY, R ;
VANLIER, JE .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (05) :382-387
[3]  
ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
[4]  
BANGA AK, 1995, PROCESSING HANDLING, P135
[5]   STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM [J].
BAZILE, D ;
PRUDHOMME, C ;
BASSOULLET, MT ;
MARLARD, M ;
SPENLEHAUER, G ;
VEILLARD, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :493-498
[6]  
Breimer DD, 1983, TOP PHARM SCI, P305
[7]  
Casalini P, 1997, J NUCL MED, V38, P1378
[8]   Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles [J].
De Jaeghere, F ;
Allémann, E ;
Feijen, J ;
Kissel, T ;
Doelker, E ;
Gurny, R .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2000, 5 (04) :473-483
[9]   TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[10]  
Gonzalez M, 1997, J BIOL CHEM, V272, P11288